54943 North Main Street
Mattawan, MI 49071-9399
Phone: 269-668-3336
Fax: 269-668-4151
www.mpiresearch.com
Contact Person: Dr. Jim Laveglia
Email: Jim.Laveglia@mpiresearch.com
|
MPI
Research providing GLP training at
the China Life Sciences Summit, July
27th & 28th in Beijing
|
| 2006-07-12 |
MATTAWAN, July 14, 2006:
As a global leader in preclinical pharmaceutical,
biopharmaceutical and medical device research
and development, MPI Research will conduct
training on Good Laboratory Practices (GLP)
compliance at the esteemed China Life Sciences
Summit, being held in Beijing, PRC on July
27-28, 2006. Jointly sponsored by the China
Center for Pharmaceutical International Exchange
(CCPIE), the China State Food & Drug
Administration (SFDA), the China Pharmaceutical
Enterprises Management Association, and the
Beijing Pharmaceutical Group Companies (BPGC),
this prestigious meeting provides a platform
for knowledge sharing by biotech and pharmaceutical
thought leaders as well as networking opportunities
among a body of international industry decision-makers.
“With one-fourth of the world’s population, China is an important
force in shaping the global pharmaceutical and medical device market,” says
MPI Research’s President and COO, William Harrison. “Our domestic
as well as our international Sponsors value the GLP standards at MPI Research,
and we are pleased to lead an educational initiative to set the bar in this arena.
We look forward to having high-level discussions about GLP’s and other
relevant topics with key players in China’s growing biopharmaceutical industry.”
MPI Research focuses on quality and timeliness in providing comprehensive preclinical
research, from early proof of concept testing to regulatory submissions. Because
of increased demands for its scientific expertise and broad scope of services,
MPI Research is enlarging its facilities on its 130-acre site while continuing
to meet the needs of its Sponsors. Yet, the service commitment goes beyond the
state-of-the-art facilities and innovative processes. The company values results,
and its team of 1,000+ employees efficiently create and implement standardized
and custom GLP research programs within the broad areas of toxicology, pathology,
efficacy, medical devices and safety pharmacology. Known for its proactive problem-solving
capabilities, it’s no accident that MPI Research has a reputation of being
the best in its field.
Visit us at the MPI Research booth at this important meeting (http://www.Chinalifescience.org)
or at www.mpiresearch.com, to learn
how we can assist you in bringing safer, better pharmaceuticals, biopharmaceuticals,
medical devices and healthcare products to the world.
Home | News
|